CHA Biotech to Raise 30 Billion KRW Through Capital Increase, All Shares Acquired by Kakao
KOSDAQ-listed company CHA Biotech announced on November 19 that it has decided to conduct a third-party allotment capital increase to raise approximately 30 billion won for purposes including the acquisition of securities of other corporations.
Through this capital increase, a total of 2,400,192 new common shares will be issued, with the issue price set at 12,499 won per share.
Hot Picks Today
![[Breaking] Samsung Electronics Management: "The Principle That Rewards Are Given Where There Are Results Has Been Upheld"](https://cwcontent.asiae.co.kr/asiaresize/93/2026052014513970767_1779256299.png)
[Breaking] Samsung Electronics Management: "The Principle That Rewards Are Given Where There Are Results Has Been Upheld"
- "It Has Now Crossed Borders": No Vaccine or Treatment as Bundibugyo Ebola Variant Spreads [Reading Science]
- "Was It You Again?" Elementary Student Involved in Last Week's Vehicle Theft Drives Off Himself This Time
- "Stocks Are Not Taxed, but Annual Crypto Gains Over 2.5 Million Won to Be Taxed Next Year... Investors Push Back"
- "Who Is Visiting Japan These Days?" The Once-Crowded Tourist Spots Empty Out... What's Happening?
The designated third-party allottee is Kakao Corporation. Kakao will acquire all 2,400,192 new shares issued through this offering.
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
![[Breaking] Samsung Electronics Labor and Management Officially Sign Tentative Agreement](https://cwcontent.asiae.co.kr/asiaresize/307/2026052022492353201A.jpg)
